Clinical Trial Search

Primary: Change From Baseline in Convenience Satisfaction Score of Treatment Satisfaction Questionnaire to Medication (TSQM-9) at Week 12 — 38.5; 38.5 score on a scale — p=0.56

Primary: User Satisfaction as Measured by the Client Satisfaction Questionnaire (CSQ-8) — 23.49; 23.97 score on a scale

Primary: Subject Satisfaction — 50 Participants

Primary: Patient Satisfaction as Measured by Giving an "Excellent" Score on a 5-point Rating — 25; 22 participants

Primary: Family Satisfaction in the ICU (FS-ICU) Questionnaire- Overall Satisfaction Score — 78.3 units on a scale

Primary: The Patients' Satisfaction With Chronic Obstructive Pulmonary Disease (COPD) Medical Treatments During a 12-month Observation Period — 64.2; 66.2; 67.1; 75.8 Unit on Scale

Primary: Subject Satisfaction When Treated With abobutulinumtoxinA in Their Glabellar Lines — 66; 38; 4; 2 Participants

Primary: Patient Satisfaction With Pain Control in Labor — 5; 5 score on a scale — p=0.16

Primary: Participant Satisfaction With Injection Device Evaluated at Week 12 for Modified Intent-to-treat (mITT) Population — 8.9; 7.6 units on a scale — p=<0.001

Primary: Overall Patient Satisfaction — 247; 53 Participants

Primary: Percentage of Participants With Improvement in Subject Global Assessment of Change at Day 30 — 94.7; 0.00 Percentage of participants

Primary: Anxiety — 2.9; 1.4 NRS

Primary: Satisfaction With Comfort of T30fA Lens — 8 score on a scale

Primary: Change From Baseline in the Rasch-transformed Score of the FACE-Q Satisfaction With Facial Appearance Scale. — 46.6 units on a scale — p=<0.0001

Primary: Patient Satisfaction Questionnaire — 8; 7.5 units on a scale

Primary: Change From Baseline in Rasch-transformed Score of FACE-Q Satisfaction With Facial Appearance Overall Scale to End of Study — 40.9; 37.8; 21.5; 32.9 score on a scale…